Developer docs
API playgroundTry for free, no card

Search company profiles

medeConnect

Full company profile

uuid002cu7b

Namestring
medeConnect
Legal namestring
M3 (EU) Ltd.
Websiteurl
medeconnect.net
Company typeenum
Private
Founded yearint
2005
Descriptiontext

medeConnect is a UK-based healthcare market research consultancy that operates as the EU/UK research brand within M3 Global Group, delivering custom-designed primary research to global pharmaceutical and healthcare organisations. Founded in 2005 and registered in England and Wales as M3 (EU) Ltd., with its EU operations headquartered at One Valentine Place, London, the firm runs a small team (11–50 employees) and serves enterprise pharmaceutical clients across the full product lifecycle. Its offering is organised into four named services — Product Development, Product Launch, Product Growth, and GP Omnibus — delivered through three integrated capabilities: methodological expertise, healthcare fluency, and client-focused thinking.

The firm's core asset is its position within M3 Global Group's network of specialist healthcare professional platforms (m3.com, MDLinx, Doctors.net.uk, MEDI:GATE, Vidal Group, M3 India, iDoctus, and M3 Global Research), which collectively reach over six million healthcare professionals worldwide. On top of this network, medeConnect operates a recurring UK general practitioner panel — the GP Omnibus — a monthly online survey drawing on 1,000 regionally representative UK GPs. The client base is exclusively enterprise pharmaceutical companies, with work covering HCPs, payers, patients and carers, and system leaders and policy influencers.

medeConnect generates revenue through project-based professional services engagements sold via direct, consultative enterprise sales. Pricing is quote-based and tailored to individual project requirements, with no publicly disclosed fee structures, no recurring SaaS subscription, and no SMB or self-serve channel. The go-to-market relies on direct engagement with pharma brand teams, supported by a modest digital presence (LinkedIn, X/Twitter, eu.m3.com) and inbound contact via reachdoctors@eu.m3.com. There is no disclosed funding history, consistent with its position as a wholly-owned subsidiary within M3 Global Group rather than a standalone, capital-raising entity.

Short descriptiontext

medeConnect is a UK-based healthcare market research consultancy, operating as the EU research brand within M3 Global Group, that delivers custom primary research and a monthly UK GP Omnibus panel to global pharmaceutical clients across the product lifecycle.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAbingdon, United Kingdom
HQ citystring
Abingdon
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare market research, pharmaceutical market research, primary market research, HCP panel surveys, medical market intelligence
NAICS code2 codes
  • Marketing Consulting Services541613
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Health Services8000
Product category
Healthcare Market Research
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Custom Healthcare Research Services
TypeProfessional Services
Description

medeConnect provides strategic, custom-designed market research studies for pharmaceutical and healthcare organisations. Revenue is generated through project-based consulting engagements that support brand and product decisions across the product lifecycle.

eu.m3.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

medeConnect is a full-service healthcare market research consultancy delivering custom primary research to pharmaceutical and healthcare organisations across the product lifecycle. Its portfolio covers Product Development research (early pipeline validation), Product Launch research (evidence-backed launch planning), Product Growth research (ongoing strategic insight), and the GP Omnibus — a monthly online survey of 1,000 regionally representative UK GPs.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

medeConnect is a full-service healthcare market research consultancy offering a unified platform of research solutions organized across the product lifecycle. The portfolio comprises four core services: Product Development (early insights for pipeline strategy), Product Launch (evidence-backed launch preparation), Product Growth (ongoing strategic insights), and GP Omnibus (monthly UK GP panel). These services are delivered through three integrated core capabilities: Methodological Expertise (qualitative and quantitative study design), Healthcare Fluency (clinical and scientific understanding), and Client-Focused Thinking (business-aligned delivery).

Product and service1 record
1Product Development Research
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeOthers
Description

Part of M3 Global Group's network of specialist healthcare platforms. m3.com provides access to Japanese healthcare professionals as part of the integrated M3 network that medeConnect operates within.

2MDLinx
Strategic tierCoreTypeOthers
Description

Part of M3 Global Group's network providing medical news and HCP engagement platforms. MDLinx serves US-based healthcare professionals as part of the integrated M3 network.

eu.m3.com
Strategic tierCoreTypeOthers
Description

UK-specific HCP platform within M3 Global Group network. The largest professional network for UK doctors, providing UK market access for research and engagement.

Strategic tierCoreTypeOthers
Description

Part of M3 Global Group's network serving Korean healthcare professionals. Provides access to Korean HCP market for integrated research services.

5Vidal Group
Strategic tierCoreTypeOthers
Description

M3 Global Group subsidiary providing drug and medical information databases, primarily serving French healthcare professionals with pharmaceutical reference data.

eu.m3.com
Strategic tierCoreTypeOthers
Description

M3 Global Group's Indian platform providing access to healthcare professionals in India's growing pharmaceutical market.

Strategic tierCoreTypeOthers
Description

M3 Global Group's Spanish and Latin American HCP platform providing medical content and engagement services to Spanish-speaking healthcare professionals.

Strategic tierCoreTypeOthers
Description

The market research division of M3 Global Group that encompasses medeConnect. Provides integrated global healthcare market research services across all M3 platforms.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers2 records
TypeBroad incumbent
Description

IQVIA is the largest global healthcare market research and analytics provider, offering primary research, real-world evidence, and commercial consulting to pharma clients. It is the dominant broad incumbent against which all niche healthcare MR firms, including medeConnect, compete on enterprise accounts.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

medeConnect

Healthcare Market Researchmedeconnect.net

medeConnect is a UK-based healthcare market research consultancy, operating as the EU research brand within M3 Global Group, that delivers custom primary research and a monthly UK GP Omnibus panel to global pharmaceutical clients across the product lifecycle.

What medeConnect does

medeConnect is a UK-based healthcare market research consultancy that operates as the EU/UK research brand within M3 Global Group, delivering custom-designed primary research to global pharmaceutical and healthcare organisations. Founded in 2005 and registered in England and Wales as M3 (EU) Ltd., with its EU operations headquartered at One Valentine Place, London, the firm runs a small team (11–50 employees) and serves enterprise pharmaceutical clients across the full product lifecycle. Its offering is organised into four named services — Product Development, Product Launch, Product Growth, and GP Omnibus — delivered through three integrated capabilities: methodological expertise, healthcare fluency, and client-focused thinking.

The firm's core asset is its position within M3 Global Group's network of specialist healthcare professional platforms (m3.com, MDLinx, Doctors.net.uk, MEDI:GATE, Vidal Group, M3 India, iDoctus, and M3 Global Research), which collectively reach over six million healthcare professionals worldwide. On top of this network, medeConnect operates a recurring UK general practitioner panel — the GP Omnibus — a monthly online survey drawing on 1,000 regionally representative UK GPs. The client base is exclusively enterprise pharmaceutical companies, with work covering HCPs, payers, patients and carers, and system leaders and policy influencers.

medeConnect generates revenue through project-based professional services engagements sold via direct, consultative enterprise sales. Pricing is quote-based and tailored to individual project requirements, with no publicly disclosed fee structures, no recurring SaaS subscription, and no SMB or self-serve channel. The go-to-market relies on direct engagement with pharma brand teams, supported by a modest digital presence (LinkedIn, X/Twitter, eu.m3.com) and inbound contact via reachdoctors@eu.m3.com. There is no disclosed funding history, consistent with its position as a wholly-owned subsidiary within M3 Global Group rather than a standalone, capital-raising entity.

medeConnect firmographics

Firmographics
Name
medeConnect
Legal name
M3 (EU) Ltd.
Website
https://medeconnect.net
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
1–10 employees
Short description
medeConnect is a UK-based healthcare market research consultancy, operating as the EU research brand within M3 Global Group, that delivers custom primary research and a monthly UK GP Omnibus panel to global pharmaceutical clients across the product lifecycle.
Ownership category
akta.pro rank

Where medeConnect is headquartered

Location

Headquarters

HQ city
Abingdon
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

medeConnect business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Custom Healthcare Research Services: medeConnect provides strategic, custom-designed market research studies for pharmaceutical and healthcare organisations. Revenue is generated through project-based consulting engagements that support brand and product decisions across the product lifecycle.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

medeConnect product offering

Product offering

Core offering

medeConnect is a full-service healthcare market research consultancy delivering custom primary research to pharmaceutical and healthcare organisations across the product lifecycle. Its portfolio covers Product Development research (early pipeline validation), Product Launch research (evidence-backed launch planning), Product Growth research (ongoing strategic insight), and the GP Omnibus — a monthly online survey of 1,000 regionally representative UK GPs.

Product overview

medeConnect is a full-service healthcare market research consultancy offering a unified platform of research solutions organized across the product lifecycle. The portfolio comprises four core services: Product Development (early insights for pipeline strategy), Product Launch (evidence-backed launch preparation), Product Growth (ongoing strategic insights), and GP Omnibus (monthly UK GP panel). These services are delivered through three integrated core capabilities: Methodological Expertise (qualitative and quantitative study design), Healthcare Fluency (clinical and scientific understanding), and Client-Focused Thinking (business-aligned delivery).

Differentiator

Problem solved

Functional benefit

Products and services

  • Product Development Research

Companies that use medeConnect

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles1 record

medeConnect technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

medeConnect partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core.

  • m3.comcoreOthersPart of M3 Global Group's network of specialist healthcare platforms. m3.com provides access to Japanese healthcare professionals as part of the integrated M3 network that medeConnect operates within.
  • MDLinxcoreOthersPart of M3 Global Group's network providing medical news and HCP engagement platforms. MDLinx serves US-based healthcare professionals as part of the integrated M3 network.
  • Doctors.net.ukcoreOthersUK-specific HCP platform within M3 Global Group network. The largest professional network for UK doctors, providing UK market access for research and engagement.
  • MEDI:GATEcoreOthersPart of M3 Global Group's network serving Korean healthcare professionals. Provides access to Korean HCP market for integrated research services.
  • Vidal GroupcoreOthersM3 Global Group subsidiary providing drug and medical information databases, primarily serving French healthcare professionals with pharmaceutical reference data.
  • M3 IndiacoreOthersM3 Global Group's Indian platform providing access to healthcare professionals in India's growing pharmaceutical market.
  • iDoctuscoreOthersM3 Global Group's Spanish and Latin American HCP platform providing medical content and engagement services to Spanish-speaking healthcare professionals.
  • M3 Global ResearchcoreOthersThe market research division of M3 Global Group that encompasses medeConnect. Provides integrated global healthcare market research services across all M3 platforms.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

medeConnect competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: IQVIA is the largest global healthcare market research and analytics provider, offering primary research, real-world evidence, and commercial consulting to pharma clients. It is the dominant broad incumbent against which all niche healthcare MR firms, including medeConnect, compete on enterprise accounts.
  • Kantar Health (now part of Lumanity / Kantar):

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

medeConnect social profiles

Digital presence

medeConnect financial estimates

Financial estimate

Revenue estimate

Valuation estimate

medeConnect leadership team

Management profile

Number of profiles

medeConnect funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

medeConnect M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about medeConnect

What does medeConnect do?

medeConnect is a full-service healthcare market research consultancy delivering custom primary research to pharmaceutical and healthcare organisations across the product lifecycle. Its portfolio covers Product Development research (early pipeline validation), Product Launch research (evidence-backed launch planning), Product Growth research (ongoing strategic insight), and the GP Omnibus — a monthly online survey of 1,000 regionally representative UK GPs.

Is medeConnect a public or private company?

medeConnect is a private company. It is classified as corporate owned and is currently operating.

When was medeConnect founded?

medeConnect was founded in 2005. It employs 1 to 10 people.

Where is medeConnect based?

medeConnect is headquartered in Abingdon, United Kingdom, in the Europe region.

How does medeConnect make money?

One revenue line is on record: custom Healthcare Research Services.

Who are medeConnect's main competitors?

Broad incumbents on record are IQVIA and Kantar Health (now part of Lumanity / Kantar).

Does medeConnect have an API?

No public API is recorded for medeConnect.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales